STAND. COM. REP. NO.  1015-18

 

Honolulu, Hawaii

                , 2018

 

RE:   H.B. No. 2631

      H.D. 1

 

 

 

 

Honorable Scott K. Saiki

Speaker, House of Representatives

Twenty-Ninth State Legislature

Regular Session of 2018

State of Hawaii

 

Sir:

 

     Your Committee on Consumer Protection & Commerce, to which was referred H.B. No. 2631, H.D. 1, entitled:

 

"A BILL FOR AN ACT RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM,"

 

begs leave to report as follows:

 

     The purpose of this measure is to enhance the Electronic Prescription Accountability System (System) to inform prescribers of the percentile ranking of their opiate prescription practices in relation to their peers by requiring the Department of Public Safety to:

 

     (1)  Annually determine, through the System, the mean and median quantity and volume of prescriptions for opiates that are Schedule II and III controlled substances within categories of practitioners of a similar specialty or practice type;

 

     (2)  Work in conjunction with the respective licensure boards to annually determine each practitioner's Schedule II and III opiate prescribing quantity and volume and standing in relation to others within the same specialty or practice type and notify practitioners who exceed the relevant mean and median; and

 

     (3)  Coordinate with the respective licensure boards to make resources available to prescribers regarding ways to change prescribing practices and incorporate alternative pain management options into practice.

 

     The Department of Public Safety commented on this measure.

 

     As affirmed by the record of votes of the members of your Committee on Consumer Protection & Commerce that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2631, H.D. 1, and recommends that it pass Third Reading.

 

 

Respectfully submitted on behalf of the members of the Committee on Consumer Protection & Commerce,

 

 

 

 

____________________________

ROY M. TAKUMI, Chair